Lifestyle Medicine and Gastroesophageal Reflux Disease in Viet Nam: Weight Management, Meal Timing, and Appropriate Evaluation

Lifestyle Medicine and Gastroesophageal Reflux Disease in Viet Nam: Weight Management, Meal Timing, and Appropriate Evaluation

Primary category: Evidence & Clinical Practice

Secondary category: Lifestyle Medicine in Viet Nam

Article type: VLMA Perspective

Last reviewed: October 30, 2026

A person who regularly experiences heartburn after dinner may begin avoiding coffee, spicy foods, and late-night meals. Another may have taken acid-suppressing medication for several months without knowing whether gastroesophageal reflux disease has actually been confirmed. Both are trying to manage uncomfortable symptoms, but their clinical needs may be quite different.

Lifestyle changes can help some people with reflux symptoms. Weight reduction may be beneficial for those with overweight or obesity, while adjustments to meal timing and sleeping position may provide relief for selected patients. Yet these measures do not address every cause of heartburn, and following a long list of dietary restrictions is not necessarily an effective treatment plan.

Gastroesophageal reflux disease, commonly referred to as GERD, occurs when reflux of stomach contents into the esophagus causes troublesome symptoms or complications. Heartburn and regurgitation are its most recognizable manifestations, but patients differ considerably in symptom patterns, underlying mechanisms, and treatment needs.

Some have visible inflammation of the esophagus, while others experience persistent symptoms despite normal findings on endoscopy. In certain cases, symptoms resembling reflux may result from another gastrointestinal disorder or an unrelated medical condition.

For healthcare professionals in Viet Nam, the challenge is to recognize when lifestyle interventions are likely to help, when medical treatment is necessary, and when further evaluation may prevent misdiagnosis or inappropriate long-term treatment.

The publication of the Vietnam Association of Gastroenterology's guideline in August 2026 provides a timely opportunity to examine these questions. It also reinforces an important principle of evidence-based Lifestyle Medicine: recommendations about daily habits are most useful when they are connected to an appropriate understanding of the condition being managed.

Heartburn Does Not Always Mean Confirmed GERD

Heartburn is usually described as a burning sensation behind the breastbone, often occurring after meals or when lying down. Regurgitation involves the return of stomach contents into the throat or mouth.

These symptoms are characteristic of gastroesophageal reflux disease, but their presence does not always establish a definitive diagnosis.

Some people experience occasional reflux symptoms without evidence of clinically significant disease. Others have frequent symptoms that substantially interfere with sleep, eating, employment, or quality of life.

Endoscopic findings also vary. Erosive reflux disease involves visible injury to the esophageal lining, while nonerosive reflux disease involves pathological reflux without visible erosive esophagitis.

Importantly, a normal endoscopic examination does not automatically establish nonerosive reflux disease. Some patients with normal endoscopy have functional heartburn or reflux hypersensitivity, conditions involving different mechanisms that may respond differently to treatment.

These distinctions matter because symptoms alone cannot reliably identify the underlying cause.

A person who develops discomfort after meals may have GERD, but functional dyspepsia, esophageal motility disorders, or other gastrointestinal conditions can produce overlapping symptoms.

Chest discomfort requires particular caution because cardiovascular disease and other serious conditions may also present with symptoms resembling heartburn.

For clinicians, the initial task is to understand the symptom pattern, identify warning signs, and determine whether the presentation supports an initial treatment approach or requires further investigation.

This is more useful than assuming that everyone with heartburn needs the same dietary restrictions or indefinite acid-suppressing medication.

Viet Nam's 2026 GERD Guideline Provides an Important Professional Reference

On August 3, 2026, the Vietnam Association of Gastroenterology published its guideline on the management of gastroesophageal reflux disease in Frontiers in Medicine.

The guideline was developed by a multidisciplinary expert panel using a structured review of scientific literature, assessment of evidence quality, and a modified Delphi consensus process.

It contains 20 recommendations covering clinical presentation, diagnosis, medical treatment, persistent symptoms, and the management of overlapping gastrointestinal conditions.

The publication is particularly relevant because it considers international evidence alongside clinical practice and healthcare resource considerations in Viet Nam.

It recognizes that GERD is not a uniform condition and that diagnostic and treatment decisions should reflect the patient's clinical presentation.

The recommendations address the appropriate use of upper gastrointestinal endoscopy, ambulatory reflux monitoring, and high-resolution esophageal manometry in selected patients. They also support lifestyle modification and optimized medical treatment while reserving invasive antireflux procedures for appropriate clinical circumstances.

An important distinction concerns the guideline's professional status.

This is a consensus guideline developed and published by the Vietnam Association of Gastroenterology. It represents an important Vietnamese professional reference, but it should not be described as a legally binding clinical guideline issued by the Ministry of Health.

Its recommendations also require individual interpretation. Not every patient with reflux symptoms needs advanced diagnostic testing, and not everyone with confirmed GERD requires the same treatment.

The publication is also consistent with a broader shift in international gastroenterology toward more precise diagnosis and individualized treatment. A narrative review published in Clinical Gastroenterology and Hepatology in October 2026 highlights advances in reflux monitoring, diagnostic classification, and treatment strategies for acid-related disorders.

These developments support an approach in which healthcare professionals consider what is known about the patient's condition, what remains uncertain, and which interventions are likely to provide meaningful benefit.

For the Vietnam Lifestyle Medicine Alliance (VLMA), this provides a useful foundation for discussing how lifestyle-related interventions can support appropriate gastroenterological care.

Weight Management Can Help, but It Is Not Necessary for Everyone

Excess body weight is a well-established risk factor for gastroesophageal reflux disease.

Increased abdominal pressure and changes affecting the gastroesophageal junction may contribute to reflux, particularly in people with overweight or obesity.

Weight reduction can improve reflux symptoms in appropriately selected patients.

The American College of Gastroenterology's 2022 guideline strongly recommends weight loss for patients with GERD who have overweight or obesity. The recommendation is supported by moderate-certainty evidence.

The Vietnamese guideline published in 2026 also recognizes weight management as an important nonpharmacological intervention.

However, advising everyone with reflux symptoms to lose weight would be inappropriate.

A person who already has a healthy body weight may gain little benefit from further weight reduction. For someone who is underweight, nutritionally depleted, or experiencing unintended weight loss, additional dietary restriction may be harmful and could delay investigation of another medical problem.

Even among people who may benefit from weight reduction, the approach should reflect age, nutritional status, associated medical conditions, physical capacity, and personal preferences.

A sustainable plan may involve improving dietary quality, adjusting excessive energy intake, and supporting appropriate physical activity rather than following an unnecessarily restrictive diet.

The relevant objective is improvement in reflux symptoms and overall health, not achieving an arbitrary body weight.

Patients should also understand that weight reduction does not guarantee complete resolution of GERD.

Some people continue to experience clinically significant reflux despite reaching a healthy weight, while others have symptoms related to mechanisms that are not primarily influenced by body weight.

For these patients, further evaluation or medical treatment may still be necessary.

Meal Timing and Nocturnal Reflux Deserve Particular Attention

The interval between eating and lying down is especially relevant for people whose symptoms occur after dinner or during sleep.

Eating a large meal shortly before bedtime may increase reflux in susceptible individuals, particularly when gastric distension and the lying position contribute to symptoms.

The American College of Gastroenterology suggests avoiding meals within approximately two to three hours of bedtime.

This is a conditional recommendation supported by low-certainty evidence, not a rigid requirement that must be followed by every patient.

The American Society for Gastrointestinal Endoscopy's 2025 guideline also recognizes avoiding meals close to bedtime as part of lifestyle management for reflux symptoms.

For someone who regularly experiences nighttime heartburn after a late dinner, adjusting the timing or size of the evening meal may be reasonable.

A person who eats a large meal immediately before lying down may benefit from eating earlier or reducing the meal's size, provided the change is practical and nutritionally appropriate.

However, daily schedules can make this difficult.

Working hours, commuting, family responsibilities, and shift work may influence meal timing in Viet Nam. Someone returning home late in the evening may have limited flexibility about when dinner is served.

Healthcare professionals should therefore help patients identify realistic changes rather than expect everyone to follow an idealized schedule.

Meal timing is also only one consideration. A patient with persistent daytime symptoms, substantial regurgitation, or complications of GERD may not experience sufficient improvement simply by eating earlier.

The patient's broader clinical condition should determine whether additional treatment or investigation is appropriate.

Sleeping Position May Help Selected Patients

Nighttime reflux can interfere with sleep and contribute to repeated discomfort.

For selected patients, elevating the head of the bed may reduce esophageal acid exposure during sleep.

Both the American College of Gastroenterology and the 2026 Vietnamese guideline support head-of-bed elevation for patients experiencing nocturnal reflux.

Appropriate elevation generally involves an inclined sleeping surface, a suitable wedge, or adjustment of the bed itself so that the upper body is elevated.

Simply placing several ordinary pillows under the head may not produce the same effect and may cause discomfort.

Sleeping on the left side may also help reduce nighttime reflux in some individuals, although the available evidence and personal responses vary.

These interventions are most relevant when symptoms are associated with lying down. They should not automatically become routine recommendations for every patient with GERD.

Someone whose symptoms occur only during daytime activities may have little reason to change their sleeping position.

The more useful question is whether a particular intervention addresses an identifiable problem and leads to meaningful improvement.

Dietary Triggers Should Be Identified Rather Than Assumed

People with reflux symptoms are frequently advised to avoid coffee, citrus fruits, chocolate, spicy foods, fatty meals, and carbonated beverages.

Some patients report worsening symptoms after consuming particular foods or drinks. However, the evidence supporting universal avoidance of these products remains inconsistent.

The Vietnam Association of Gastroenterology's 2026 guideline discusses a survey involving approximately 4,400 people in Viet Nam.

The survey identified associations between reflux symptoms and several dietary or behavioral factors, including overeating, greasy foods, sour or spicy dishes, citrus fruits, carbonated beverages, alcohol, stress, and disturbed sleep.

These findings provide useful information about reported symptom patterns.

However, an association observed in a survey does not establish that a particular food causes GERD or that eliminating it will improve outcomes for everyone.

A person who repeatedly experiences heartburn after a large, high-fat meal may benefit from adjusting its size or composition. Another may tolerate similar foods without difficulty.

Coffee is a familiar example. Some people notice that coffee aggravates their symptoms, while others do not experience a consistent relationship.

It would therefore be inappropriate to tell everyone with GERD that they must permanently stop drinking coffee without considering their individual response.

The same applies to spicy dishes, acidic foods, and other ingredients commonly consumed in Viet Nam.

Instead of providing a long list of prohibited foods, healthcare professionals can explore when symptoms occur, what the person usually eats, and whether the same pattern is repeated.

A brief record of meals, symptom timing, and relevant activities may help identify possible triggers. Selected changes can then be introduced and reviewed to determine whether they provide meaningful relief.

This approach helps preserve nutritional adequacy and dietary variety while avoiding restrictions that may be unnecessary or difficult to sustain.

Persistent symptoms despite repeated dietary changes should prompt reassessment rather than an expanding list of foods to eliminate.

Tobacco, Alcohol, and Stress Have Different Implications

Tobacco use, alcohol consumption, and psychological stress may influence reflux symptoms, but they should not be treated as having identical mechanisms or levels of supporting evidence.

Smoking cessation is appropriate for overall health and may also improve reflux symptoms in some patients.

Alcohol can aggravate symptoms in susceptible individuals, particularly when consumed in larger amounts or with meals that provoke reflux.

However, the relationship between alcohol consumption and reflux symptoms varies. Abstaining from alcohol should not be presented as a guaranteed treatment for GERD, even though avoiding harmful alcohol use remains important for general health.

Stress and disturbed sleep also deserve consideration.

People with persistent reflux symptoms may report greater discomfort during periods of psychological distress. Stress can influence symptom perception, sleep, gastrointestinal function, and health-related behaviors.

However, worsening symptoms during stressful periods does not establish that GERD is caused by stress or that relaxation alone can treat pathological reflux.

Some patients may benefit from psychological support or appropriately directed behavioral interventions, particularly when symptoms overlap with disorders of gut–brain interaction.

These interventions should be selected according to the clinical presentation rather than introduced automatically.

The important distinction is that managing psychological distress can be valuable without implying that persistent physical symptoms are imaginary or solely psychological.

Recognizing When Reflux Symptoms Require Further Investigation

A central message of the 2026 Vietnamese guideline is that symptoms and response to medication are not always sufficient to establish a definitive diagnosis of GERD.

Heartburn and regurgitation are characteristic symptoms, and an empirical course of acid-suppressing treatment may be appropriate for selected patients without warning signs.

The American College of Gastroenterology recommends an initial eight-week proton pump inhibitor trial for patients with typical reflux symptoms who have no alarm features.

However, improvement during treatment does not prove that the symptoms were caused by pathological gastroesophageal reflux.

This distinction becomes particularly important when medication continues for prolonged periods or when more invasive treatment is being considered.

Initial clinical assessment should consider the frequency, severity, and duration of symptoms, associated features, previous treatment, medication use, and relevant medical history.

Healthcare professionals should also identify signs that may indicate a more serious condition.

Difficulty swallowing, painful swallowing, gastrointestinal bleeding, persistent vomiting, unexplained weight loss, and unexplained anemia may require timely investigation.

Progressive swallowing difficulty deserves particular attention.

Chest pain requires a separate level of caution. Reflux can cause discomfort behind the breastbone, but cardiac and other serious causes should be considered before the symptoms are attributed to GERD.

Acute chest pain with concerning features requires urgent medical evaluation.

The aim is to identify patients who can reasonably begin with clinical assessment and conservative management while ensuring that important alternative diagnoses are not overlooked.

Extraesophageal Symptoms Require Diagnostic Caution

Some people presenting with suspected GERD do not report typical heartburn or regurgitation.

Instead, they may experience chronic cough, hoarseness, throat discomfort, recurrent throat clearing, or respiratory symptoms.

These complaints may coexist with gastroesophageal reflux, but they can also result from unrelated conditions.

Chronic cough, for example, may be associated with respiratory disease, upper airway disorders, medication-related effects, or several other causes.

The 2026 Vietnamese guideline recommends multidisciplinary assessment when extraesophageal symptoms occur in the absence of typical reflux symptoms.

The American Gastroenterological Association's 2023 clinical practice update similarly emphasizes that such symptoms are often multifactorial and that reflux should not automatically be assumed to be the cause.

For patients with isolated extraesophageal symptoms, objective investigation may be more appropriate than repeated empirical courses of acid-suppressing medication.

Clinical assessment may involve gastroenterology, respiratory medicine, otolaryngology, or other relevant specialties, depending on the presenting symptoms.

The purpose is not to perform extensive testing in everyone with a chronic cough or hoarseness. It is to avoid attributing persistent symptoms to reflux without sufficient evidence while ensuring that alternative conditions receive appropriate attention.

A Normal Endoscopy Does Not Necessarily Exclude GERD

Upper gastrointestinal endoscopy is an important investigation for evaluating erosive esophagitis, esophageal strictures, Barrett's esophagus, and other structural abnormalities.

It may be appropriate when alarm symptoms are present, when symptoms persist despite suitable treatment, when complications are suspected, or when a patient is being considered for an antireflux procedure.

However, normal endoscopic findings do not necessarily exclude gastroesophageal reflux disease.

Some patients have pathological reflux without visible injury to the esophageal lining. Others experience heartburn despite physiological levels of esophageal acid exposure.

These groups should not automatically be treated as having the same condition.

The Lyon Consensus 2.0, published in Gut in 2024, provides an updated framework for interpreting endoscopic findings and esophageal reflux monitoring.

The 2026 Vietnamese guideline adopts a similar emphasis on objective diagnostic evidence.

Within the Vietnamese guideline, typical reflux symptoms accompanied by Los Angeles grade B, C, or D erosive esophagitis, biopsy-confirmed Barrett's esophagus, or reflux-related esophageal stricture can provide conclusive evidence supporting GERD.

When endoscopic findings are normal or inconclusive, ambulatory esophageal reflux monitoring may help determine whether pathological acid exposure is present.

The Vietnamese guideline retains esophageal acid exposure exceeding 6% on 24-hour monitoring as a conservative criterion supporting a conclusive GERD diagnosis.

Although the guideline discusses evidence suggesting that lower acid exposure thresholds may be relevant in some Asian populations, it does not adopt a lower threshold as an independent universal criterion for definite GERD.

Results between established normal and abnormal ranges require interpretation alongside symptoms, endoscopic findings, reflux episodes, symptom association, and other supportive measurements.

The value of diagnostic testing lies in resolving clinically important uncertainty. More testing does not automatically mean better care, and investigations should be selected according to whether their results are likely to influence management.

Suspected GERD and Confirmed GERD Require Different Testing Strategies

Contemporary reflux care distinguishes between patients whose GERD diagnosis remains unproven and those who already have objective evidence of disease.

This distinction affects how further investigations should be performed and interpreted.

For someone with typical symptoms but no conclusive evidence of GERD, ambulatory reflux monitoring performed without acid-suppressing medication may help establish whether pathological reflux is present when objective confirmation is clinically needed.

When available and appropriate, prolonged wireless pH monitoring can provide information about acid exposure over several days.

For patients with previously confirmed GERD who continue to experience symptoms despite optimized treatment, a different approach may be appropriate.

In selected circumstances, combined pH-impedance monitoring while the patient is receiving acid suppression can help determine whether ongoing acid or nonacid reflux is associated with persistent symptoms.

The choice depends on the clinical question and should be made by an appropriately qualified specialist.

High-resolution esophageal manometry has a different role.

It assesses esophageal motor function and may be useful when a motility disorder is suspected or when evaluation is needed before an antireflux procedure.

It should not be treated as a routine diagnostic test for everyone with heartburn.

These distinctions are especially important in healthcare systems where advanced esophageal function testing is not available at every facility.

The Vietnamese guideline recognizes that access to specialized investigations varies and that routine testing of every patient with reflux symptoms would create unnecessary burdens.

A practical approach is to begin with appropriate clinical assessment, provide treatment when indicated, and arrange specialist investigation when diagnostic uncertainty or inadequate treatment response justifies it.

Acid-Suppressing Medication Remains an Important Treatment

Lifestyle-related interventions may improve symptoms, but many patients with GERD require medication.

Proton pump inhibitors remain central to treatment because they effectively suppress gastric acid secretion and promote healing of erosive esophagitis.

The 2026 Vietnamese guideline strongly supports proton pump inhibitor treatment, particularly in patients with erosive reflux disease.

A treatment course of approximately eight weeks is commonly recommended for healing erosive esophagitis, with subsequent decisions based on clinical findings and treatment response.

For patients with confirmed nonerosive reflux disease, the Vietnamese guideline recommends standard-dose proton pump inhibitor therapy for approximately four to eight weeks.

Treatment duration and subsequent management may differ according to the patient's symptoms, diagnosis, and response.

For selected patients with mild symptoms, lifestyle and dietary adjustments may be combined with symptom-relieving treatments such as alginate-based preparations.

Others require acid suppression to achieve adequate symptom control or mucosal healing.

Correct medication use also matters.

For many conventional proton pump inhibitors, administration before a meal improves acid suppression. Inadequate timing or inconsistent use may contribute to an apparently poor treatment response.

However, instructions differ between products and should follow the prescribed regimen and approved product information.

The Vietnamese guideline also discusses potassium-competitive acid blockers as an alternative class of acid-suppressing medicines.

These medicines have demonstrated clinical efficacy in selected international studies, particularly for severe erosive esophagitis.

However, the guideline explicitly stated that this medicine class was not yet approved or commercially available in Viet Nam at the time of its publication in August 2026.

This was the regulatory and market-access situation described in the guideline at that time. It should not be assumed to establish the approval status of every product at a later date.

The status of any specific medicine must be verified against current Vietnamese pharmaceutical requirements when treatment is considered.

For Lifestyle Medicine, the important point is that medication and lifestyle interventions may address different aspects of care.

Someone may benefit from eating earlier while still requiring acid suppression to heal esophageal inflammation.

These approaches should not be presented as competing alternatives when both are clinically appropriate.

Long-Term Proton Pump Inhibitor Use Requires Review, Not Automatic Discontinuation

Concerns about prolonged proton pump inhibitor use are common.

Some patients worry about potential adverse effects, while others continue taking medication for years without a clear understanding of why it was prescribed.

Both situations deserve clinical review.

The American Gastroenterological Association's 2022 guidance on proton pump inhibitor deprescribing recommends regularly reviewing the indication for continued treatment.

Patients without a clear reason for long-term therapy may be suitable for a supervised attempt to reduce or discontinue medication.

However, some patients have established indications for ongoing acid suppression.

These include selected patients with severe erosive esophagitis, reflux-related esophageal ulcers or strictures, Barrett's esophagus, or other complications for which continued treatment is appropriate.

Such patients should not be encouraged to stop therapy simply because symptoms have improved or because they have adopted healthier habits.

Concerns about medication safety should also be interpreted carefully.

Several observational studies have identified associations between long-term proton pump inhibitor use and adverse health outcomes. However, observational associations do not necessarily establish that the medicine caused those outcomes.

Treatment decisions should consider the strength of the evidence, the actual clinical indication, expected benefits, potential harms, and patient preferences.

For suitable patients without a continuing indication for daily therapy, intermittent or on-demand treatment may be considered according to the diagnosis and treatment response.

When medication is reduced or discontinued, some patients may experience temporary worsening of upper gastrointestinal symptoms associated with rebound acid secretion.

This possibility should be explained as part of an appropriate follow-up plan.

The objective is neither indefinite treatment without review nor medication discontinuation at all costs. It is to use treatment appropriately while minimizing unnecessary burden and preserving effective disease control.

Persistent Heartburn Does Not Always Mean More Acid Suppression Is Needed

Some patients continue to experience heartburn or regurgitation despite taking proton pump inhibitors.

The appropriate response is not necessarily to increase the dose repeatedly or add further medication.

Before describing a patient as having refractory GERD, clinicians should determine whether GERD has been objectively established and whether treatment has been optimized.

The 2026 Vietnamese guideline defines refractory GERD in the context of persistent symptoms despite optimized medical treatment in patients with objective evidence supporting the diagnosis.

This distinction helps avoid labeling all persistent heartburn as treatment-resistant reflux disease.

Several other conditions may contribute to symptoms.

Reflux hypersensitivity involves symptoms associated with reflux events despite physiological overall esophageal acid exposure.

Functional heartburn involves persistent heartburn without pathological acid exposure or an appropriate symptom–reflux relationship after relevant causes have been excluded.

Some patients also have overlapping functional dyspepsia, esophageal motility disorders, or other disorders of gut–brain interaction.

These conditions may require different treatment approaches.

Simply increasing acid suppression may provide little benefit when pathological acid exposure is not the main mechanism responsible for symptoms.

In selected patients, treatment may involve appropriately directed behavioral interventions, neuromodulatory therapy, or further assessment of overlapping disorders.

Such decisions require clinical evaluation and should not be introduced on the assumption that persistent symptoms are psychological.

The symptoms are real whether their mechanisms involve excessive acid exposure, heightened esophageal sensitivity, altered motility, or overlapping gastrointestinal disorders.

Identifying the underlying mechanism can help patients avoid unnecessary medication escalation and repeated investigations.

Antireflux Procedures Require Careful Patient Selection

Some patients with objectively confirmed GERD continue to experience substantial symptoms despite appropriate medical treatment.

Others may have anatomical abnormalities or complications for which specialist intervention is relevant.

Endoscopic or surgical antireflux procedures can be considered in selected circumstances.

However, persistent symptoms alone do not establish that an invasive procedure will be beneficial.

The Vietnamese guideline emphasizes appropriate patient selection and objective evidence of GERD before endoscopic or surgical treatment.

Specialist assessment may involve upper gastrointestinal endoscopy, ambulatory reflux monitoring, esophageal manometry, and evaluation of relevant anatomical or motility abnormalities.

These investigations help clarify whether the symptoms are likely to respond to a procedure and whether important contraindications or alternative diagnoses are present.

Established surgical approaches, including fundoplication, can be effective in appropriately selected patients.

Newer endoscopic techniques may also have a role, but their supporting evidence, technical requirements, long-term outcomes, and availability differ.

The Vietnamese guideline recognizes that evidence concerning some newer antireflux procedures remains limited in the local setting.

Lifestyle-related support may continue before and after specialist treatment, but it should not delay necessary clinical evaluation.

Equally, the availability of an advanced procedure should not become a reason to intervene when the diagnosis or expected benefit remains uncertain.

Making GERD Care Practical in Viet Nam

The clinical value of lifestyle advice depends partly on whether patients can realistically follow it.

For one person, the main problem may be interrupted sleep after late dinners. For another, it may be persistent regurgitation after large meals or anxiety about eating certain foods.

Someone working irregular shifts may find it difficult to change meal timing, while another patient may already have attempted numerous dietary restrictions without meaningful relief.

These differences should influence the care plan.

A useful consultation can begin by identifying the most troublesome symptom and considering whether there is a plausible, modifiable contributing factor.

For someone whose symptoms consistently occur after late meals, adjusting dinner timing may be a reasonable starting point.

A person with overweight or obesity may benefit from an appropriate weight-management plan.

Someone who has already made extensive dietary changes but continues to experience substantial symptoms may need further clinical evaluation rather than additional restrictions.

Recommendations should also reflect the food environment and family eating patterns in Viet Nam.

Patients should not be expected to purchase expensive supplements, follow an unfamiliar diet, or substantially disrupt family routines without evidence that these changes are likely to help.

Vietnamese meals can often be adjusted through portion sizes, meal timing, preparation methods, and identification of individual symptom triggers rather than wholesale elimination of traditional foods.

Physical activity also deserves appropriate consideration.

Regular exercise supports general health and may contribute to weight management when indicated. However, no particular exercise program has been established as a universal treatment for GERD.

Activities should be selected according to general health needs, personal tolerance, and relevant clinical circumstances.

The contribution of Lifestyle Medicine lies in helping healthcare professionals translate evidence into practical support without creating unnecessary restrictions or implying that persistent symptoms reflect a failure to follow healthy habits.

Evaluating Whether GERD Care Is Improving

A patient may report fewer episodes of heartburn after adjusting meal timing or beginning medication.

That improvement matters, but it should be assessed alongside the person's broader clinical condition.

Relevant outcomes may include heartburn frequency, regurgitation, nighttime symptoms, sleep disruption, medication requirements, daily functioning, and health-related quality of life.

Validated symptom questionnaires may help clinicians evaluate changes consistently, although they cannot replace clinical assessment or objective investigation when needed.

For healthcare organizations, evaluation should also consider whether patients receive appropriate assessment and follow-up.

Those with alarm symptoms should be investigated according to clinical needs. Patients with persistent symptoms should have their diagnosis and treatment response reviewed, while individuals being considered for invasive procedures should receive appropriate specialist evaluation.

Long-term medication use also deserves attention.

A patient receiving continued acid suppression should have a documented clinical indication and an appropriate follow-up plan.

When the diagnosis remains uncertain, the relevant question is whether additional testing will clarify management rather than simply increase the number of investigations performed.

Healthcare organizations may count consultations, prescriptions, endoscopic procedures, or completed dietary counseling sessions.

These figures provide information about service activity but do not independently establish that care has improved.

A more meaningful evaluation considers whether patients receive accurate diagnosis, effective symptom management, appropriate investigation, and necessary follow-up without avoidable treatment or procedural harm.

Professional and Legal Responsibilities in Viet Nam

Lifestyle Medicine can contribute to GERD care through evidence-based education, appropriate nutritional support, weight management when indicated, and health behavior counseling.

However, diagnosing GERD, prescribing medication, interpreting endoscopic findings, performing esophageal function testing, and determining the need for invasive treatment are regulated clinical activities.

In Viet Nam, these activities are governed by the Law on Medical Examination and Treatment No. 15/2023/QH15, as amended, and applicable implementing regulations.

Consolidated Document No. 26/VBHN-VPQH dated February 26, 2026, provides an updated consolidated reference to the law.

Healthcare professionals must act within their qualifications, competence, and legally authorized scopes of practice.

Professional education, membership, or international certification in Lifestyle Medicine does not independently authorize an individual to diagnose GERD, prescribe acid-suppressing medicines, interpret specialized esophageal investigations for clinical decisions, or perform endoscopic or surgical procedures.

The 2026 Vietnam Association of Gastroenterology guideline provides an important Vietnamese professional reference, while international guidance from the American College of Gastroenterology, American Gastroenterological Association, and other organizations provides additional scientific evidence.

These recommendations do not automatically replace Vietnamese professional requirements or establish the regulatory approval, reimbursement status, or availability of particular medicines and procedures.

Personal health information must also be appropriately protected.

Symptoms, medical histories, medication records, and results from endoscopy or esophageal monitoring may constitute identifiable health information.

The Law on Personal Data Protection No. 91/2025/QH15 and Government Decree No. 356/2025/NĐ-CP, both effective January 1, 2026, establish relevant requirements concerning personal data processing and protection.

Healthcare organizations and educational activities involving identifiable patient information must consider applicable legal bases, confidentiality obligations, security safeguards, retention requirements, and necessary permissions.

For VLMA, professional education should remain clearly distinguished from individualized clinical assessment and regulated medical treatment.

Implications for the Vietnam Lifestyle Medicine Alliance

Gastroesophageal reflux disease provides a practical example of how Lifestyle Medicine can contribute to established healthcare without becoming a separate treatment system.

Weight management, appropriate meal timing, selected dietary adjustments, and other health behaviors may help reduce symptoms in certain patients.

However, their benefits depend on the underlying condition, symptom pattern, and personal circumstances.

For some people, relatively simple changes may provide meaningful relief. Others require acid-suppressing medication, further diagnostic evaluation, or specialist treatment.

For VLMA, an appropriate contribution is to support healthcare professionals in understanding these differences through evidence-based education, scientific knowledge exchange, and responsible collaboration.

Educational resources could examine the evidence supporting lifestyle recommendations, the limitations of symptom-based diagnosis, appropriate use of acid-suppressing medication, and the distinction between confirmed GERD and other causes of persistent heartburn.

Professional discussions could also consider how healthcare organizations improve diagnostic pathways, review long-term medication use, and reduce unnecessary investigation or treatment.

Such work would benefit from collaboration with appropriately qualified specialists in gastroenterology, internal medicine, clinical nutrition, and related fields.

VLMA is a physician-led professional platform operated by Vietnam Lifestyle Medicine Alliance Company Limited. Its activities focus on evidence-based professional education, capability development, scientific knowledge exchange, and collaboration.

VLMA does not independently diagnose GERD, prescribe or adjust acid-suppressing medication, perform gastrointestinal investigations, interpret esophageal function tests for individual clinical decisions, or provide invasive antireflux treatment.

Its intended contribution is to strengthen professional understanding and support the responsible interpretation and application of scientific evidence within authorized healthcare services.

Better GERD Care Requires More Than a List of Foods to Avoid

GERD is often discussed through familiar advice: eat smaller meals, lose excess weight, avoid coffee, and do not lie down immediately after eating.

Some of these recommendations can be useful. However, they do not have the same evidence base, and their relevance depends on the patient's symptoms and clinical condition.

Someone with nocturnal reflux may benefit from adjusting meal timing or sleeping position. A person with overweight or obesity may experience improvement through appropriate weight management.

Another patient may require medication to heal esophageal inflammation, while persistent symptoms in someone with normal reflux measurements may point toward a different underlying mechanism.

The 2026 Vietnamese guideline and current international evidence reinforce the importance of bringing these considerations together.

The objective is not to encourage every patient to make as many lifestyle changes as possible. It is to identify which interventions are relevant, provide appropriate treatment, and recognize when further investigation is needed.

For healthcare professionals in Viet Nam, effective care should also consider the practical realities of eating patterns, employment, family responsibilities, healthcare access, and the patient's ability to maintain recommended changes.

Someone should not have to eliminate numerous familiar foods or continue medication indefinitely without understanding why.

Equally, improvement in symptoms should not lead to the assumption that an established complication has resolved or that prescribed treatment is no longer required.

The contribution of Lifestyle Medicine is to support appropriate, sustainable changes in daily habits while ensuring that gastroesophageal reflux disease is evaluated accurately, treated when necessary, and followed up according to the patient's clinical needs.

Selected References

1. Dao HV, Mai BH, Dao LV, et al. Vietnam Association of Gastroenterology (VNAGE) Guideline on the Management of Gastroesophageal Reflux Disease. Frontiers in Medicine. 2026;13:1890726. Published August 3, 2026. DOI: 10.3389/fmed.2026.1890726.

2. Katz PO, Dunbar KB, Schnoll-Sussman FH, Greer KB, Yadlapati R, Spechler SJ. ACG Clinical Guideline for the Diagnosis and Management of Gastroesophageal Reflux Disease. American Journal of Gastroenterology. 2022;117(1):27–56. DOI: 10.14309/ajg.0000000000001538.

3. Yadlapati R, Gyawali CP, Pandolfino JE, et al. AGA Clinical Practice Update on the Personalized Approach to the Evaluation and Management of GERD: Expert Review. Clinical Gastroenterology and Hepatology. 2022;20(5):984–994.e1. DOI: 10.1016/j.cgh.2022.01.025.

4. Gyawali CP, Yadlapati R, Fass R, et al. Updates to the Modern Diagnosis of GERD: Lyon Consensus 2.0. Gut. 2024;73(2):361–371. DOI: 10.1136/gutjnl-2023-330616.

5. Desai M, Ruan W, Thosani NC, et al. American Society for Gastrointestinal Endoscopy Guideline on the Diagnosis and Management of GERD: Summary and Recommendations. Gastrointestinal Endoscopy. 2025;101(2):267–284. DOI: 10.1016/j.gie.2024.10.008.

6. Chen JW, Vela MF, Peterson KA, Carlson DA. AGA Clinical Practice Update on the Diagnosis and Management of Extraesophageal Gastroesophageal Reflux Disease: Expert Review. Clinical Gastroenterology and Hepatology. 2023;21(6):1414–1421.e3. DOI: 10.1016/j.cgh.2023.01.040.

7. Targownik LE, Fisher DA, Saini SD. AGA Clinical Practice Update on De-Prescribing of Proton Pump Inhibitors: Expert Review. Gastroenterology. 2022;162(4):1334–1342. DOI: 10.1053/j.gastro.2021.12.247.

8. Shaheen NJ, Howden CW, Yadlapati R, Katz PO. Modern Diagnosis and Management of Acid-Related Disorders. Clinical Gastroenterology and Hepatology. Narrative review published online October 1, 2026. DOI: 10.1016/j.cgh.2026.09.030.

9. Rea BL, Cheema S, Lanza S, et al. Lifestyle Medicine Core Competencies: 2025 Update. American Journal of Lifestyle Medicine. First published online October 28, 2025. DOI: 10.1177/15598276251379821.

10. Office of the National Assembly of Viet Nam. Consolidated Document No. 26/VBHN-VPQH: Law on Medical Examination and Treatment. February 26, 2026.

11. National Assembly of Viet Nam. Law on Personal Data Protection No. 91/2025/QH15. June 26, 2025. Effective January 1, 2026.

12. Government of Viet Nam. Decree No. 356/2025/NĐ-CP Detailing Selected Provisions and Implementation Measures of the Law on Personal Data Protection. December 31, 2025. Effective January 1, 2026.

Editorial and Professional Scope Note

This article presents an educational and professional perspective of the Vietnam Lifestyle Medicine Alliance on the contribution and limitations of evidence-based Lifestyle Medicine in gastroesophageal reflux disease care, based on information reviewed through October 30, 2026.

It is intended for professional information, education, and scientific knowledge exchange. It does not constitute a clinical practice guideline, individualized medical advice, a diagnostic or treatment protocol, dietary prescription, weight-management treatment plan, medication recommendation, or authoritative interpretation of Vietnamese law.

Vietnam Lifestyle Medicine Alliance (VLMA) is a physician-led professional platform operated by Vietnam Lifestyle Medicine Alliance Company Limited. VLMA is not a licensed medical examination or treatment facility, gastroenterology treatment provider, medical licensing authority, or healthcare accreditation organization. It does not independently diagnose GERD, prescribe or adjust acid-suppressing medication, perform gastrointestinal endoscopy or esophageal function testing, interpret investigations for individual clinical decisions, or provide invasive antireflux treatment.

Clinical assessment, diagnosis, prescribing, specialized investigations, medical and surgical treatment, and follow-up must be undertaken by appropriately qualified and authorized healthcare professionals and facilities within their applicable scopes of practice and in accordance with relevant Vietnamese requirements.

Lifestyle-related interventions should not delay or replace clinically indicated medical treatment, diagnostic assessment, specialist referral, or emergency care. Progressive swallowing difficulty, gastrointestinal bleeding, unexplained weight loss, persistent vomiting, significant anemia, or other concerning symptoms require appropriate medical evaluation. Acute chest pain or symptoms suggesting a serious cardiovascular condition require urgent assessment.

International clinical guidelines, professional consensus statements, and scientific studies are cited for educational purposes. Their inclusion does not imply that they automatically have regulatory force in Viet Nam or that VLMA has formally adopted, delivered, validated, endorsed, or certified any GERD management or treatment program discussed in this article.

The illustrative patient situations are hypothetical and do not describe actual VLMA clinical activities or identifiable patients.